HOLLY KINGERY: Open Payments
NPI 1609435304 · WESTFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,144 in 75 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $211 · 2025 $2,144
Food & beverage: $2,060Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $757 |
| ABBVIE INC. | 15 | $356 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $247 |
| Regeneron Healthcare Solutions, Inc. | 3 | $163 |
| Lilly USA, LLC | 8 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $138 |
| GENZYME CORPORATION | 2 | $99 |
| Madrigal Pharmaceuticals | 1 | $90 |
| PFIZER INC. | 3 | $59 |
| Novo Nordisk Inc | 1 | $32 |
Products named: TREMFYA, DUPIXENT, RINVOQ, OMVOH, XIFAXAN, ENTYVIO, GATTEX, REZDIFFRA.
Industry payments across IN — which companies pay providers there.
